Arritmia

Andrographis paniculata has one of the strongest clinical evidence bases of any herbal medicine for upper respiratory tract infections. A 2017 systematic review of 33 RCTs (7,175 patients) found significant symptomatic relief for acute RTIs. Multiple placebo-controlled trials with the SHA-10 extract showed significant reductions in cold symptoms beginning at day 2. It has been used in Indian and Chinese traditional medicine for colds and influenza for centuries.

Andrographolide is the principal bioactive diterpenoid of Andrographis paniculata responsible for its anti-cold and antiviral effects. It inhibits NF-κB via covalent binding to the p50 subunit. Clinical evidence from multiple RCTs using standardized Andrographis extracts (SHA-10) documents significant reductions in cold symptom severity and duration. It also shows direct in vitro antiviral activity against influenza A.

A randomized, double-blind, placebo-controlled trial (n=199 adults, 12 weeks) found larch arabinogalactan (4.5 g/day) significantly reduced the number of participants affected by common cold (p=0.038) and decreased cold episodes by approximately 23% in the per-protocol analysis. A second vaccine model study showed enhanced antibody response to the pneumococcal vaccine. The immunostimulatory mechanism remains under investigation but likely involves NK cell activation and gut-associated lymphoid tissue (GALT) pathways.

A randomized, double-blind, placebo-controlled trial tested a blend containing Aronia melanocarpa in 61 participants prone to upper respiratory tract infections over 60 days and found a significant reduction in URTI incidence. In vitro studies have further shown that Aronia juice can inhibit the replication of multiple influenza virus strains, including those resistant to oseltamivir.

Astragalus membranaceus is used in Traditional Chinese Medicine as an immune tonic for preventing recurrent respiratory infections. Laboratory and clinical studies show astragalus improves white blood cell function, increases interferon levels, and raises antibody titers. NCCIH and EBSCO recognize it as a proposed treatment for cold and flu prevention. It is best used prophylactically rather than for acute treatment.

Yeast-derived (1,3)-(1,6)-beta-D-glucan has clinical evidence for reducing common cold frequency. A double-blind, randomized, placebo-controlled multicenter RCT found 900 mg/day for 16 weeks reduced symptomatic cold episodes by 25% vs. placebo in individuals with recurring infections. Beta-glucan activates innate immune cells via dectin-1 receptors, enhancing macrophage and NK cell function.

B. animalis subsp. lactis BB-12 has been studied specifically for cold/flu outcomes in healthy adults, with documented reductions in URTI days concurrently with enhanced immune cell activity. Studies in college students using BB-12 with LGG showed improved health-related quality of life during self-reported cold/flu episodes. The evidence base overlaps substantially with the upper respiratory health category.

B. lactis BB-12 has been investigated in randomized trials for its effect on cold/flu incidence and severity in healthy adults; B. lactis Bl-04 significantly reduced the risk of upper respiratory illness in a large RCT. A pediatric RCT with a mixture including B. lactis HN019 shortened fever duration by approximately 2 days. Cochrane review evidence includes B. lactis strains for prevention of URTIs.

Boneset has a deep traditional history as a remedy for influenza and the common cold, and limited scientific evidence partially supports this use. A 1981 controlled clinical trial (Gassinger et al.) found that a homeopathic preparation of E. perfoliatum D2 reduced common cold symptoms comparably to aspirin in 53 outpatients. In vitro work (Derksen et al., 2016, Journal of Ethnopharmacology) demonstrated that hydroalcoholic extracts inhibit influenza A virus attachment to host cells. No modern, well-powered RCTs exist for the whole-herb preparation.

Camphor is an active ingredient in widely used OTC chest rubs (including those listed on FDA DailyMed) indicated for temporary relief of nasal congestion and cough associated with the common cold. A 2023 PMC bibliometric review confirmed clinical articles addressing camphor/menthol compounds for upper respiratory infection symptoms. Camphor and menthol activate TRP channel M8, believed to inhibit respiratory reflexes and reduce cough.

C. sinensis is a major dietary source of vitamin C, which per NIH ODS and Cochrane review evidence may modestly shorten cold duration and reduce severity when supplemented regularly. The immune-supporting roles of vitamin C (antioxidant, leukocyte function, antibody production) are well documented. Traditional use across multiple cultures also cites C. sinensis for colds and respiratory support.

Bovine colostrum contains high concentrations of immunoglobulins, lactoferrin, and growth factors supporting immune defense against respiratory viruses. Several RCTs found bovine colostrum supplementation reduces incidence and duration of upper respiratory infections and flu-like illness. A 2007 Italian RCT found colostrum superior to flu vaccination alone for preventing flu episodes. ConsumerLab lists colostrum among cold and flu supplements.

Echinacea, particularly E. purpurea, has been studied in dozens of randomized controlled trials for prevention and treatment of the common cold and flu. A 2024 meta-analysis showed it reduced recurrent respiratory infections, complications, and antibiotic use significantly vs. placebo. Multiple RCTs and Cochrane reviews indicate a probable modest benefit for reducing cold duration and severity.

Echinacea purpurea is the most clinically studied Echinacea species for cold and flu. Multiple RCTs and systematic reviews indicate it reduces duration and severity of upper respiratory tract infections. A 2015 noninferiority trial comparing it to oseltamivir for influenza showed comparable efficacy. Cochrane reviewers concluded it was effective in 5 of 6 treatment trials reviewed.

EGCG is the principal bioactive catechin of green tea with well-documented anti-influenza and antiviral activity. It inhibits influenza hemagglutinin and neuraminidase, blocking viral entry and release. Clinical RCTs of green tea catechin preparations (predominantly EGCG) reduced influenza incidence by ~90% in healthcare workers in one RCT. It also modulates innate immune responses relevant to cold/flu defense.

Black elderberry (Sambucus nigra) has clinical evidence for reducing duration and severity of influenza and common cold symptoms. A 2019 meta-analysis of four RCTs found significant reduction in upper respiratory symptom duration and severity. Two early placebo-controlled RCTs showed elderberry syrup shortened influenza illness by approximately 4 days vs. placebo. A 2016 RCT in air travelers found significantly fewer cold episode days.

Among the best-supported clinical uses of eleuthero. A large 1986 placebo-controlled trial in 1,376 patients during an influenza epidemic found significantly fewer complications (pneumonia, bronchitis) in the eleuthero group. Additional studies in children and a Kan Jang combination formula further support efficacy against upper respiratory infections.

Multiple randomized controlled trials and a systematic review support elderberry's ability to reduce the duration and severity of cold and flu symptoms. The EMA lists elderflower as a traditional herbal medicinal product for cold symptoms. Evidence for flu (influenza) is stronger than for common cold. One contradictory RCT (2020) found no benefit, so overall certainty remains moderate.

C. speciosa is documented in TCM for influenza and the common cold, and laboratory studies have identified neuraminidase (NA) inhibitory activity in isolated compounds, including quercetin and 3,4-dihydroxybenzoic acid, relevant to anti-influenza action. This anti-influenza activity is supported by in vitro mechanistic studies, though no human clinical trials exist.

Garlic (Allium sativum) has been used in traditional medicine across cultures for millennia for respiratory infections. A Cochrane review identified one qualifying RCT showing allicin-containing garlic capsules significantly reduced cold episodes (24 vs. 65) over 12 weeks. A separate RCT of aged garlic extract improved NK and γδ-T cell function and reduced cold/flu symptom severity. Evidence is promising but limited by small number of qualifying trials.

A 2014 Cochrane review found insufficient evidence from a single qualifying RCT (146 participants) to confirm garlic prevents or treats the common cold, though that trial suggested fewer cold occurrences. A separate RCT showed aged garlic extract enhanced NK and γδ-T cell function and reduced cold/flu symptom severity. Evidence is promising but limited.

Pelargonium sidoides (African geranium) has extensive clinical evidence including a Cochrane review for acute respiratory infections including cold and flu symptoms. Ethnobotanical evidence also links P. graveolens to cold and flu treatment, including ACE2 inhibition research.

Both Panax ginseng and Panax quinquefolius have been studied for cold and flu prevention. Several RCTs found North American ginseng extract (COLD-fX/CVT-E002) reduced cold frequency and duration. Evidence is described as inconsistent by NCCIH but some RCTs show benefit, particularly for prevention. ConsumerLab notes preliminary evidence that ginseng may reduce flu infection risk and enhance flu vaccine effectiveness.

Green chiretta (Andrographis paniculata) is among the best-evidenced herbal medicines for the common cold and influenza. Multiple RCTs and a major systematic review and meta-analysis of 33 RCTs (7,175 patients) confirm significant reductions in symptom severity and duration. Standardised extracts (SHA-10) at 1,200 mg/day for 5–7 days are most studied.

Green tea catechins, particularly EGCG, have documented anti-influenza activity and have been studied for cold and flu prevention. A Japanese RCT found green tea catechin gargling for 3 months reduced confirmed influenza incidence from 10% to 1% in healthcare workers vs. placebo. Multiple epidemiological studies associate green tea consumption with reduced respiratory infection risk. EBSCO and NCCIH list green tea extract as a proposed cold and flu treatment.

Honey has strong clinical evidence as a nighttime cough suppressant in children with upper respiratory infections. Multiple RCTs and a 2018 Cochrane review found honey reduces nocturnal cough frequency and severity better than placebo and several OTC cough medications in children aged 1 year and older. The AAFP and NCCIH recognize honey as one of very few safe and effective treatments for cold-associated cough in children.

L. acidophilus has been evaluated in multi-strain probiotic RCTs for reducing cold symptom severity and duration. A 2009 RCT (Leyer et al.) found children consuming L. acidophilus combined with B. lactis had shorter and less severe cold and flu symptoms. A 2025 RCT using a formula containing L. acidophilus PBS066 alongside two other strains demonstrated alleviation of cold symptoms and reduction of pro-inflammatory cytokines in healthy adults over 12 weeks. Effects are consistently observed in combination formulations rather than with L. acidophilus alone.

An open-label, parallel-group pilot study in 1,783 schoolchildren found that consumption of L. brevis KB290 drink (~6 billion CFU/day) was associated with a statistically significantly lower incidence of physician-confirmed influenza (15.7% vs. 23.9%, p<0.001). A subsequent RCT of heat-killed KB290 plus β-carotene in healthy adults showed a significant reduction in influenza incidence in those under 40 years, though not in the overall population.

L. casei Shirota specifically has been studied in RCTs for common cold and flu. Fermented milk with L. casei Shirota reduced incidence of cold/flu symptoms in healthy medical students under examination stress. A placebo-controlled trial in endurance athletes tested L. casei Shirota for common cold infection and herpes virus antibodies, providing evidence of immunological effect in a physically stressed population.

L. paracasei 8700:2 combined with L. plantarum HEAL9 significantly reduced the incidence and severity of community-acquired common colds in a large RCT of 898 healthy adults. L. paracasei (L. casei 431) enhanced immune response to influenza vaccination in a 1,104-subject RCT and reduced upper respiratory symptom duration.

Lactoferrin is an iron-binding glycoprotein found in colostrum and mucosal secretions with documented antiviral activity against influenza and respiratory viruses. Several RCTs found oral bovine lactoferrin supplementation reduced common cold episodes in children and adults. It inhibits viral adsorption by binding host cell heparan sulfate proteoglycans and has direct virucidal activity. ConsumerLab and EBSCO list lactoferrin among cold and flu supplements.

Lemon's vitamin C content supports immune defense against respiratory infections. A 2006 Swiss clinical review found vitamin C intake improved symptoms and shortened duration of respiratory tract infections including the common cold. However, preventive effects in non-deficient individuals are modest.

Luteolin is a flavone with documented anti-influenza and anti-inflammatory activity. In vitro studies demonstrate inhibition of influenza A replication and neuraminidase activity. Luteolin is a major active constituent of thyme, forsythia, honeysuckle, and other traditional cold/flu herbs. Its NF-κB inhibitory effects reduce cold/flu-related inflammatory cytokines. Preclinical evidence is robust though clinical RCTs for isolated luteolin in cold/flu are limited.

Malabar nut has been used traditionally for common colds and is an ingredient in KanJang, a multi-herb combination shown in two RCTs to reduce cold symptoms including coughing and nasal congestion. A COVID-19 open-label RCT using 500 mg A. vasica also showed all patients recovered without disease progression.

In vitro CDC cell-culture data show monolaurin activity against influenza virus and coronaviruses, and a 2025 human cohort study linked higher serum monolaurin to reduced SARS-CoV-2 infection risk. Activity against enveloped respiratory viruses is consistent across multiple in vitro studies, though no randomized trials of oral monolaurin for cold or influenza prevention or treatment in humans exist.

NAC has clinical evidence for reducing influenza-like illness severity. A landmark Italian double-blind RCT found elderly individuals taking NAC 600 mg twice daily during flu season had significantly fewer symptomatic flu episodes and milder symptoms vs. placebo. NAC acts as a mucolytic and glutathione precursor supporting antioxidant defense during respiratory infections. AAFP and ConsumerLab list NAC among effective cold and flu remedies.

Orange is one of the richest dietary sources of vitamin C, which has been evaluated in over 30 placebo-controlled trials for the common cold. Regular vitamin C supplementation reduces cold duration by ~8% in adults and ~14% in children (Cochrane review). It is not effective at preventing colds in the general population but shows preventive benefit in athletes.

Pelargonium sidoides root extract (EPs 7630/Umcka) has strong clinical evidence for reducing duration and severity of the common cold and acute bronchitis. A 2013 Cochrane review (11 RCTs) supported its efficacy for acute RTIs. It is used in South African Zulu and Xhosa traditional medicine and is licensed as a phytomedicine in Germany. A key RCT found EPs 7630 significantly reduced cold severity score and shortened duration by 2 days.

Bee propolis has demonstrated antiviral and immunomodulatory activity relevant to cold and flu. A combination RCT found echinacea plus propolis plus vitamin C significantly reduced respiratory infection frequency in children vs. placebo. Propolis flavonoids and caffeic acid derivatives show antiviral activity against influenza viruses and rhinovirus in vitro. ConsumerLab and EBSCO list propolis among cold and flu supplements.

Quercetin is a flavonoid with documented anti-influenza and antiviral mechanisms and clinical evidence for reducing upper respiratory infection incidence in athletes. A double-blind RCT found quercetin (1000 mg/day) significantly reduced URTI incidence from 45% to 5% vs. placebo in endurance athletes. It inhibits influenza neuraminidase and blocks viral replication. A 2020 meta-analysis confirmed quercetin reduces URTI duration and severity.

Rose hips are among the richest natural sources of vitamin C, which has well-documented roles in reducing the duration and severity of common cold symptoms. Meta-analyses of vitamin C supplementation show an 8–14% reduction in cold duration in adults. Traditional use of rose hip tea for cold-season immune support is extensively documented and well corroborated by the vitamin C pharmacology.

Sambucus nigra (black elderberry) is the botanical source of elderberry preparations studied in multiple RCTs for cold and flu. Two RCTs demonstrated shortened influenza duration by ~4 days vs. placebo. A 2016 RCT in air travelers found significantly fewer cold episode days. A 2019 meta-analysis confirmed reduction in upper respiratory symptom duration and severity.

The inner bark and shoots of spruce species have long been used for colds and influenza by Native North American peoples and European herbalists. Scientific research into Norway spruce (Picea abies) inner bark has demonstrated immunomodulatory properties. Spruce needle oil is a standard ingredient in European cold remedies due to its expectorant, antiseptic, and mucolytic actions.

Thymus vulgaris preparations are recognised by the EMA HMPC for traditional use in productive coughs associated with colds. Clinical trials with thyme-ivy and thyme-primrose combinations show significant reductions in cough and associated symptoms during upper respiratory infections. Thyme possesses antiviral, antibacterial, and spasmolytic properties that are relevant to cold and flu symptom management.

T. cordifolia has been clinically investigated for upper respiratory infections. A randomized open-label trial in 150 mild COVID-19 patients found 500 mg T. cordifolia extract for 14 days reduced hsCRP at mid-treatment, and a combination with Adhatoda vasica significantly shortened viral clearance time. Its immune-stimulating properties via arabinogalactan and immunomodulatory alkaloids support this use.

Vitamin A supports the mucosal epithelial barriers of the upper respiratory tract and modulates innate and adaptive immune responses relevant to cold and influenza viruses. Observational data link lower serum vitamin A with increased influenza/pneumonia-related mortality. However, RCT evidence specifically for cold/flu prevention in replete populations is limited and inconsistent.

Vitamin C is one of the most-studied supplements for cold prevention and treatment. A 2013 Cochrane review of 29 trials (>11,000 participants) found regular supplementation does not prevent colds in the general population but modestly reduces duration (8% in adults, 14% in children) and severity. Benefits are more pronounced in people under severe physical stress such as marathon runners. NCCIH and AAFP confirm a modest symptomatic benefit.

Vitamin D supplementation reduces risk of acute respiratory infections, particularly in deficient individuals. A 2017 Cochrane meta-analysis of 25 RCTs (>11,000 participants) found it reduced ARI risk overall, with greatest benefit in those severely deficient. NCCIH notes that correcting deficiency may help prevent flu and other respiratory infections. Mechanism involves induction of cathelicidin and defensins in respiratory epithelium.

Cholecalciferol (vitamin D3) is the primary supplemental form evaluated in respiratory infection trials. Meta-analyses including the 2017 Cochrane analysis (25 RCTs, >11,000 participants) confirm it reduces ARI risk, with greatest benefit in deficient individuals. Jolliffe et al. 2021 IPD meta-analysis (46 RCTs, >75,000 participants) confirmed benefit. It induces cathelicidin and defensins in respiratory mucosa.

Willow bark's antipyretic and analgesic properties extend to fever and symptoms associated with the common cold and influenza. The EMA's HMPC and ESCOP formally list fever associated with the common cold and headache as recognized therapeutic indications, based on its long-standing use. Health Canada's natural health product monograph also recognizes this use. These are classified as traditional use with well-established documentation rather than prospective RCT-level evidence for this specific condition.

Zinc lozenges are among the best-studied supplements for common cold treatment. Multiple meta-analyses confirm that zinc acetate and gluconate lozenges containing >75 mg/day elemental zinc shorten cold duration in adults by approximately 33–37%. The NCCIH and AAFP both recognize zinc as an effective treatment for cold symptoms in adults. Benefits are dose- and formulation-dependent.

The essential oil from A. spectabilis leaves has a documented traditional use for treating colds and nasal congestion in Himalayan folk medicine. Multiple ethnobotanical sources from Nepal corroborate its use as a cold remedy. No controlled human studies have evaluated this indication.

Ajwain is a widely used traditional remedy across Ayurvedic and Unani medicine for colds and flu symptoms, including nasal congestion, cough, and sore throat. Steam inhalation with ajwain is a common home practice. Ethnopharmacological surveys consistently list common cold among its primary indications; clinical trials are absent.

Allspice is widely documented in traditional herbal medicine for colds and flu, especially in Caribbean and Central American folk practice. Its antimicrobial, antipyretic, and warming expectorant properties are cited as rationales. No human clinical trials exist for allspice in cold and flu management.

The root of S. cusia (Nan-Ban-Lan-Gen) is a classical TCM remedy for influenza and cold with fever, with documented use spanning over a millennium in Chinese medicine. In vitro inhibition of influenza virus has been reported for root preparations. Traditional use is well-documented across multiple authoritative sources.

Astragalin (kaempferol-3-glucoside) is a flavonoid glycoside found in Astragalus and other plants with anti-inflammatory and antiviral properties documented in preclinical studies. As a constituent of plants traditionally used for respiratory infections, it contributes to the immunostimulatory profile, though direct clinical evidence for cold/flu specifically is limited to traditional context.

Basil is used in Ayurveda, TCM, and traditional European herbalism for colds, coughs, and respiratory infections. Constituents such as eugenol, linalool, and rosmarinic acid have antimicrobial and antiviral properties in vitro. No human RCTs have evaluated basil specifically for cold or flu endpoints.

Bayberry root bark powder was historically a core ingredient in 'composition powder,' a widely used 19th-century home remedy for colds, flu, and chills. TCM records also document bayberry use for cold and flu for over 2,000 years. No human clinical trial evidence supports this use.

Ayurvedic and Unani traditions extensively document the use of belleric myrobalan fruit for cough, cold, and throat-related conditions. Classical texts describe combinations of T. bellirica powder with salt, long pepper, and honey for cough and cold relief. Its antimicrobial activity against respiratory pathogens provides some mechanistic support, but no dedicated human clinical trials for cold or flu have been conducted.

N. sativa has a documented history of use in Islamic, Unani, and Middle Eastern traditional medicine for cold, fever, and respiratory infections. Its immunomodulatory, antimicrobial, and antiviral properties are supported by experimental evidence, though specific RCTs in cold/flu are limited.

Black pepper has an extensive history of traditional use across Ayurvedic, traditional Chinese, and folk medicine systems for cold and flu symptoms, valued for its warming, antimicrobial, and immune-stimulating properties. Piperine's documented immunomodulatory, antimicrobial, and anti-inflammatory activities provide mechanistic plausibility.

Black spruce is listed in traditional aromatherapy and pharmacopoeia sources for colds, flu, and respiratory weakness. Its essential oil's antimicrobial and expectorant properties support its traditional use for symptomatic relief of cold and flu. No controlled human trials have been performed.

Blessed thistle has been used traditionally as an expectorant and antimicrobial agent to address colds, respiratory infections, and flu-like illness. Its essential oil has demonstrated in vitro antibacterial activity against organisms such as Staphylococcus aureus. In vitro antiviral activity of aqueous extracts has also been reported in tissue culture. No human trials support these uses.

Spleen extracts have been used historically to support resistance to infection including common respiratory illnesses. Tuftsin stimulates macrophage-mediated innate immunity relevant to bacterial and viral pathogens. This is a traditionally documented use with preclinical biological plausibility, but no human clinical trials support efficacy against colds or influenza.

B. falcatum (Chai Hu) is a classical TCM herb for the early and mid-stages of febrile respiratory illnesses including colds and flu, particularly in the Shao Yang pattern (alternating fever and chills). It is a primary ingredient in Xiao Chai Hu Tang, historically used for these conditions in China and Japan for over 2,000 years.

Cajuput oil is one of the most consistently documented traditional remedies for cold and flu across Southeast Asia and Australia, used by inhalation or chest application to ease symptoms. It is an established ingredient in commercial cold-relief products such as Olbas Oil. Its primary constituent, 1,8-cineole, has demonstrated mucolytic and decongestant properties in studies on related compounds, though dedicated cajuput clinical trials are lacking.

Indigenous Amazonian communities traditionally used camu camu as a remedy for colds, flu, and respiratory ailments, leveraging its high vitamin C content and antioxidant properties. Vitamin C's role in reducing cold duration is supported by meta-analyses, but specific clinical trials on camu camu for cold or flu have not been published.

Cassia bark is documented in TCM and multiple traditional medicine systems as a warming remedy for colds, influenza-type illness, and cold-related aches. In vitro data support antiviral activity of C. cassia bark oil against influenza virus. No human clinical trials specifically for cold and flu were identified.

Cayenne pepper is a longstanding traditional remedy for cold and flu, used to break up mucus congestion, induce sweating (diaphoretic action), and support the immune response. Its vitamin C and beta-carotene content provide antioxidant support. Clinical RCT evidence for cayenne specifically reducing cold or flu severity or duration is absent.

Chamomile (Matricaria chamomilla) is used in traditional European medicine for sore throat, pharyngeal inflammation, and nasal congestion associated with cold and flu. Commission E and ESCOP approve chamomile for inflammatory conditions of the oral and pharyngeal mucosa. Steam inhalation of chamomile is a centuries-old traditional cold remedy. EBSCO lists chamomile as a proposed natural treatment for cold and flu.

Chrysanthemum has a long and well-documented TCM use for early-stage cold and flu, including fever, sore throat, nasal congestion, and headache. The Pharmacopoeia of the People's Republic of China lists it for 'common cold with wind-heat pattern.' Limited modern clinical evidence exists; antimicrobial and anti-inflammatory properties provide partial scientific rationale.

Coltsfoot has documented traditional use across Europe and Asia for cold and flu symptoms. Tussilago farfara leaves were used in traditional Austrian medicine internally as tea or syrup for viral infections, flu, and colds. No human clinical trials support this specific indication.

Dog Rose hips have been used for centuries across European, Greek, Roman, and traditional German herbal medicine as a remedy to support immunity against colds, flu, and febrile illness, primarily attributed to their exceptionally high vitamin C content. There is no dedicated RCT of Rosa canina specifically for cold or flu; the benefit is inferred from its vitamin C content and documented immune-supportive properties.

Elecampane has been used in European, Ayurvedic, and Chinese traditional medicine for coughs and upper respiratory symptoms associated with colds. The British Herbal Pharmacopoeia lists it as an antitussive and antiseptic expectorant. No clinical trials for cold or flu specifically have been conducted.

Eucalyptus oil and its primary component 1,8-cineole (eucalyptol) have documented expectorant, mucolytic, and anti-inflammatory properties for cold and flu symptoms. Commission E approves eucalyptus oil for respiratory tract catarrh. AAFP identifies topical eucalyptus-containing ointments as effective for cold symptoms in children. An RCT found 1,8-cineole significantly improved non-purulent rhinosinusitis resolution vs. placebo.

Forsythia suspensa (Lian Qiao) is a cornerstone herb in Traditional Chinese Medicine for febrile respiratory conditions equivalent to cold and flu, co-formulated with honeysuckle in the classical Yin Qiao San. Active forsythiaside A has demonstrated antiviral activity against influenza A in vitro. EBSCO includes Forsythia as part of proposed TCM treatments for cold and flu.

Ginger (Zingiber officinale) has been used across Asian, European, and Middle Eastern traditional medicine for thousands of years for colds, flu, sore throats, and coughs. Gingerols and shogaols have documented antiviral and anti-inflammatory properties in preclinical studies including anti-RSV and anti-rhinovirus activity. EBSCO lists ginger as an 'other proposed natural treatment' for cold and flu. Clinical RCT evidence specifically for cold/flu is limited.

Goldenseal is widely used in combination with echinacea in commercial cold-and-flu preparations and has a documented history as a traditional anti-infective. However, the NCCIH and Merck Manual both state that efficacy of goldenseal as a cold remedy has not been proved in clinical studies.

Traditional medicine across India, Tibet, China, and Sri Lanka has used amla for centuries to treat the common cold. Its high vitamin C content and documented immunomodulatory effects are mechanistically supportive. A COVID-19 add-on RCT (amla as adjunct therapy) has been published.

The EMA's Committee on Herbal Medicinal Products (HMPC) adopted an EU herbal monograph for GMT specifically for traditional use in relieving cough associated with cold and mild gastrointestinal discomfort. This represents one of the highest-quality traditional use designations available. GMT also possesses antimicrobial and immunomodulatory phytochemicals relevant to cold and flu management.

Ho wood is traditionally used in aromatherapy to treat colds and flu, particularly via diffusion or inhalation, owing to its antimicrobial and immune-supportive properties. This use is documented in multiple aromatherapy sources.

Lonicera japonica (Japanese honeysuckle, Jin Yin Hua) is a cornerstone herb in Traditional Chinese Medicine for febrile respiratory infections including cold and flu, formulated in classical Yin Qiao San. Chlorogenic acid and luteolin constituents have documented anti-influenza and anti-inflammatory activity in vitro. EBSCO lists honeysuckle as part of proposed TCM treatments for cold and flu.

Horehound has been used since ancient Rome as a remedy for colds and catarrh, and is listed in German Commission E monographs as a traditional cold remedy. The EMA HMPC bases its positive opinion on traditional use with at least 30 years of documented safe use within Europe. No placebo-controlled human trials for cold or flu specifically have been conducted.

Horseradish root has a centuries-long tradition as a remedy for colds and flu. The volatile isothiocyanates (particularly allyl isothiocyanate) are believed to stimulate mucus clearance and exert antimicrobial activity. Traditional dosing was approximately 20 g/day of fresh root. Clinical trials on horseradish alone for cold/flu are absent, but its use is well-documented in European herbal medicine.

Hyssop (Hyssopus officinalis) is used in traditional European herbal medicine for cough, bronchitis, and upper respiratory catarrh associated with cold and flu. Commission E approves hyssop for catarrhs of the upper respiratory tract and cough. Its essential oil and flavonoids have expectorant, antispasmodic, and antimicrobial properties. EBSCO lists hyssop among proposed natural treatments for cold and flu.

H. italicum EO is traditionally used for cold and flu across Mediterranean Europe. The EO has demonstrated in vitro antibacterial activity against cold/flu-associated respiratory pathogens, and the plant's anti-inflammatory properties are pharmacologically relevant, but no clinical human trials for cold or flu specifically have been conducted.

Lemon balm (Melissa officinalis) is used in European herbal medicine for cold-associated symptoms including mild fever, insomnia, and upper respiratory irritation. Commission E approves lemon balm for nervous sleep disorders. Multiple RCTs confirmed its efficacy for herpes simplex cold sores. In vitro studies show activity against influenza A and B, RSV, and rhinovirus. EBSCO lists lemon balm as a proposed natural treatment for cold and flu.

Lemongrass is used in several traditional medicine systems for cold and flu symptoms including sore throat, fever, and nasal congestion. In Singapore, C. citratus is specifically used to alleviate cold and flu symptoms and sore/itchy throats. Antimicrobial properties provide mechanistic plausibility but dedicated human clinical trials are absent.

Licorice root (Glycyrrhiza glabra/G. uralensis) is used in traditional medicine systems worldwide for sore throat, cough, and respiratory infections associated with cold and flu. Commission E approves licorice root for catarrhs of the upper respiratory tract. Glycyrrhizin has documented antiviral activity against influenza and other respiratory viruses. EBSCO lists licorice root as a proposed natural treatment for cold and flu.

In traditional European medicine, S. vulgaris bark was used as an infusion, decoction, or alcoholic extract for cold and cough treatment. This use is documented across multiple European countries including Poland, Bulgaria, Italy, and Greece, with preclinical studies showing antiviral and antimicrobial activity that supports biological plausibility.

Lime has a long history of traditional use for colds, coughs, sore throats, and fever in Southeast Asia and the Americas. The scientific basis for vitamin C and citrus flavonoids supporting immune defense during infections is well-established, though lime-specific RCTs for cold and flu endpoints are absent.

Marjoram is documented across Moroccan, European, and Asian traditional medicine for treatment of colds, flu, and fever. Its documented antimicrobial, expectorant, and antipyretic properties provide a pharmacological basis for these uses.

Marshmallow root (Althaea officinalis) is used in traditional European herbal medicine for sore throat and dry cough associated with cold and flu. Commission E and ESCOP approve marshmallow root for irritation of oral and pharyngeal mucosa and associated dry cough. Its mucilaginous polysaccharides coat and soothe irritated mucous membranes. EBSCO lists marshmallow as a proposed natural treatment for cold and flu.

Indigenous Australians—specifically the Bundjalung people of New South Wales—have documented traditional use of inhaled crushed M. alternifolia leaves and infusions for colds, coughs, and upper respiratory infections. No RCTs specifically testing TTO for cold or flu outcomes have been published.

Menthol oil is the primary active component of peppermint used for cold and flu symptom relief including nasal congestion, sore throat, and cough. AAFP identifies topical menthol-containing ointments as established effective treatments for cold symptoms in children. Commission E approves menthol-containing peppermint oil for upper respiratory catarrh. Menthol activates TRPM8 cold receptors for perceived decongestant effect.

Peppermint is a long-standing traditional remedy for cold and flu symptoms, included in the German Commission E monograph for this use. Its menthol content provides symptomatic relief of nasal congestion and associated discomfort. Peppermint also has in vitro antiviral and diaphoretic properties, though robust clinical trials specifically for cold/flu endpoints are lacking.

Mulberry leaf has documented, multi-century traditional use in TCM for cold and flu symptoms, specifically Wind-Heat type presentations with fever, sore throat, cough, and headache. It is listed in the Chinese Pharmacopoeia for these indications. No standalone human RCT for cold/flu outcomes exists.

Mullein (Verbascum thapsus) has been used in traditional European and Native American medicine for centuries for cough, bronchitis, and respiratory catarrh associated with cold and flu. Saponins, mucilage, and flavonoids contribute expectorant and soothing effects. EBSCO lists mullein as a proposed natural treatment for cold and flu. ConsumerLab notes mullein is often promoted for lung conditions and cold symptoms.

Mustard is widely used in folk medicine for cold and flu symptom relief, primarily as a chest plaster to alleviate congestion and as a foot bath to induce warming and perspiration. AITC has documented broad-spectrum antimicrobial activity. The tradition spans Western, Ayurvedic, and East Asian medicinal systems.

Myrrh is traditionally used as an immune stimulant and expectorant during cold and flu season, with documented use in reducing nasal congestion. It is classed as having antiviral activity in the pharmacological literature. No human clinical trials for cold or influenza specifically exist.

Onion has been used in traditional medicine across many cultures for centuries as a remedy for colds and flu, including cough, sore throat, and fever. Its well-documented antimicrobial and immune-stimulating properties provide pharmacological plausibility. No dedicated human RCTs on cold or flu outcomes have been identified.

Oregano (Origanum vulgare) oil and its principal compound carvacrol have documented antimicrobial and antiviral activity against respiratory pathogens. Commission E approves oregano herb for upper respiratory catarrh. EBSCO lists oregano as a proposed natural treatment for cold and flu. Carvacrol and thymol disrupt viral lipid membranes and inhibit influenza replication in vitro.

P. orientalis stems and leaves are traditionally used in TCM and Korean folk medicine to treat cold symptoms, coughs, and flu-like illnesses. Multiple systematic reviews confirm this ethnomedicinal use. No human clinical trials specifically evaluating cold or influenza outcomes have been identified.

Peppermint (Mentha × piperita) and its active compound menthol provide symptomatic relief for nasal congestion, sore throat, and cough associated with cold and flu. Commission E and ESCOP recognize peppermint oil for upper respiratory catarrh. The AAFP identifies topical menthol-containing ointments as established effective treatments for cold symptoms in children. Menthol stimulates TRPM8 cold receptors, producing a decongestant sensation.

Perilla has a 2,000-year documented history in TCM for treating wind-cold type colds, and is used similarly in Vietnamese and Japanese traditional medicine at cold onset. Modern pharmacological data show antimicrobial and immune-modulatory properties. No human RCTs specifically testing perilla for cold or influenza have been identified.

Pine needles have been used traditionally for centuries to make tea for treating colds and coughs, valued for high vitamin C content and immune-supportive antioxidants. Hippocrates used pine preparations for bacterial infection and immune support. Native Americans used pine needle teas for respiratory infections.

Plantago lanceolata is recognized by the European Commission for treating common cold and has ESCOP endorsement for respiratory catarrh. P. major has antiviral properties attributed to caffeic acid and phenolic compounds. Traditional use for colds across European, Chinese, and Asian medicine is extensive.

Plantago major is a traditional Chinese and European folk medicine for colds and flu-like symptoms. It is listed among classic applications for cold, cough, fever, and hoarseness in traditional records. Antimicrobial and anti-inflammatory properties support the rationale. In vitro antiviral activity against respiratory viruses and immunostimulatory properties have been demonstrated.

Platycodon root is a foundational ingredient in traditional Northeast Asian formulas for colds and flu, addressing cough, sore throat, and phlegm. Korean and Japanese traditional medicines have used it for acute respiratory infections for centuries. Modern antiviral preclinical evidence provides biological plausibility, but dedicated human RCTs for cold and flu are lacking.

Platycodon root has been used for millennia across Chinese, Japanese, and Korean traditions to treat upper respiratory symptoms associated with colds, including cough, sore throat, and phlegm. The Japanese Kampo formula saikatsugekito, which includes platycodon root, was historically used during influenza pandemics. No placebo-controlled RCTs in cold or influenza patients have been published for platycodon as monotherapy.

Radish is documented across Asian and Middle Eastern traditional medicine systems as a remedy for common cold symptoms including congestion, sore throat, and cough. RxList lists colds and tendency toward infections among its folk indications. Scientific evidence for radish-specific antiviral or cold-relieving effects in humans is lacking.

Colds and fevers are among the oldest documented traditional uses of red root in Native American medicine. Multiple ethnobotanical sources record its use for colds and influenza-like illnesses. The herb's antimicrobial, astringent, and immune-supporting properties form the proposed basis. No controlled clinical trials exist.

Rosa californica hips were used during and before World War II for their high vitamin content, and indigenous Californian traditions valued the plant for combating illness including cold and flu-like conditions. Rose hips of the Rosa genus broadly are a traditional vitamin C source used across many cultures for respiratory infections.

Sage (Salvia officinalis) is approved by Commission E for inflammatory conditions of oral and pharyngeal mucosa including sore throat—a hallmark cold symptom. An RCT found sage/echinacea throat spray non-inferior to chlorhexidine/lidocaine spray for sore throat in upper respiratory infections. EBSCO lists sage as a proposed natural treatment for cold and flu. Rosmarinic acid and essential oil constituents contribute antimicrobial and anti-inflammatory effects.

Willow bark (salicin) has a long-documented traditional use for reducing fever and relieving symptoms associated with colds and influenza. Its antipyretic action via salicylate metabolism parallels that of aspirin. No dedicated clinical RCTs for cold/flu specifically have been conducted with salicin.

Schizonepeta (Jing Jie) has been used in TCM for over 2,000 years as a primary herb for early-stage colds and flu. It is prescribed to release the exterior, induce mild perspiration, and relieve chills, fever, sore throat, and headache. It appears in classical formulas such as Jing Fang Bai Du San. No rigorous human RCTs isolating Schizonepeta alone for cold/flu exist.

One of siler root's most extensively documented traditional applications is treatment of wind-cold syndrome corresponding to cold and flu—including chills, fever, headache, and body aches. It appears in classical formulas for these presentations and is listed in the Chinese Pharmacopoeia for these indications. Scientific evidence is preclinical only.

Slippery elm bark (Ulmus rubra) is used in North American traditional medicine for sore throat, cough, and pharyngeal irritation associated with cold and flu. The FDA recognizes slippery elm bark as a safe and effective OTC oral demulcent for sore throat. EBSCO lists slippery elm as a proposed natural treatment for cold and flu. It has been used by Native American tribes for respiratory ailments for centuries.

Smartweed is listed as a traditional remedy for the common cold in multiple ethnobotanical sources, and WebMD's monograph cites this use. The diaphoretic, antimicrobial, and anti-inflammatory properties provide a plausible multi-modal basis.

Thyme (Thymus vulgaris) is licensed by the German Commission E for treatment of bronchitis, upper respiratory catarrh, and coughs associated with cold and flu. Thymol and carvacrol have documented expectorant, antispasmodic, and antimicrobial properties. An RCT found thyme-ivy syrup significantly reduced acute bronchitis symptoms vs. placebo. EBSCO lists thyme as a proposed natural treatment for cold and flu.

White oak bark tea has traditional use for symptoms of cold and flu, including fever, cough, and congestion. It has been described as a substitute for quinine in intermittent fevers. No clinical evidence from controlled human trials exists.

White willow bark has a long documented history as an antipyretic for fever associated with colds and influenza. Its polyphenols and flavonoids have shown antiseptic and fever-reducing properties in laboratory studies. No dedicated clinical trials for cold or flu have been conducted. Traditional use is recorded across ancient Egyptian, Greek, Chinese, and European herbal systems.

Yarrow (Achillea millefolium) is approved by Commission E and ESCOP for fever and cold. It has been used in European, Asian, and Native American herbal traditions as a diaphoretic for febrile illness including cold and flu. Sesquiterpene lactones, flavonoids, and essential oil constituents provide anti-inflammatory and antipyretic effects. EBSCO includes yarrow as a proposed natural treatment for cold and flu.